Product Qualification

Successfully filed for 2 qualifications for pharmaceutical excipients from CDE
The 3D microcarriers independently developed by CytoNiche—"Gelatin Microcarrier" and "Gelatin Microcarrier Tablet for Cells", were evaluated to successfully qualify for pharmaceutical excipient by the Center for Drug Evaluation of the National Medical Products Administration on December 7, 2020 and February 24, 2021, respectively (registration number: F20200000496, F20210000003) and were approved. The product is the first domestic pharmaceutical microcarrier that is applicable for the cell drug development.
Completed the filing of 1 DMF qualification for pharmaceutical excipients from US FDA
(https://www.fda.gov/drugs/drug-master-files-dmfs/list-drug-master-files-dmfs), "Gelatin Microcarrier Tablet for Cells", the first domestic product for the production and preparation of cell therapy and regeneration therapy, completed the filing of the DMF qualification for pharmaceutical excipients (DMF: 35481). It is also the only microcarrier product in the DMF filing list announced on the official website of the US FDA.

Scientific and Technological Achievements
-
71
numberApplied for 71 Chinese patents
-
15
numberApplied for 15 international patents
-
2
SumCompleted the filing of 2 qualifications for pharmaceutical excipients from CDE
-
1
SumCompleted the filing of 1 DMF qualification for pharmaceutical excipients from US FDA
-
2
SumCompleted the filing of 2 qualifications for first-class medical devices
-
30
PiecePublished more than 30 SCI articles
-
1
SumSelected in 1 project of the Zhongguancun Subversive Technology Research and Development and Achievement Transformation
Certified by the intellectual property management system
Certified by the ISO9001 quality management system
Certified by the ISO13495 medical device quality management system
Quality and Safety

Certified by the ISO9001 quality management system and ISO13495 medical device quality management system
CytoNiche adheres to the concept of providing customers with high-quality products and attaches great importance to product quality. The design and construction of the manufacturing platform comply with the relevant regulations of the GMP and ISO.The quality management system follows the GMP and ISO standards, and thus avoiding the contamination, errors, and confusion in the process to the greatest extent, and ensuring the safety and effectiveness of products.
Safety Evaluation by the National Institutes for Food and Drug Control and Jiangsu Center for Safety Evaluation of Drugs
For the microcarrier materials and lysis buffer of CytoNiche, a series of safety evaluation experiments have been completed by the third-party institutions (National Institutes for Food and Drug Control, Jiangsu Center for Safety Evaluation of Drugs), and summary reports have been formulated.On this basis, CytoNiche has worked with the National Institutes for Food and Drug Control to establish the testing methods and standards for detecting the specific amino acids in raw microcarrier materials and the residues with enzyme activities in the lysis buffer.


News about Innovation


Cutting-Edge Research | 3D Microcarrier as a Delivery Tool to Assist Gene-Modified Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes

AHM 细胞微球组装与3D打印结合的新策略
-
Phone
- Service hotline+86 400-012-6688
-
E-mail
- E-mailwangal@cytoniche.com
- TOP